These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26175688)

  • 1. The application of global sensitivity analysis in the development of a physiologically based pharmacokinetic model for m-xylene and ethanol co-exposure in humans.
    Loizou GD; McNally K; Jones K; Cocker J
    Front Pharmacol; 2015; 6():135. PubMed ID: 26175688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstruction of Exposure to m-Xylene from Human Biomonitoring Data Using PBPK Modelling, Bayesian Inference, and Markov Chain Monte Carlo Simulation.
    McNally K; Cotton R; Cocker J; Jones K; Bartels M; Rick D; Price P; Loizou G
    J Toxicol; 2012; 2012():760281. PubMed ID: 22719759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of solvent central nervous system toxicity and ethanol interactions using a human population physiologically based kinetic and dynamic model.
    MacDonald AJ; Rostami-Hodjegan A; Tucker GT; Linkens DA
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):165-76. PubMed ID: 12052002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age.
    Allen BC; Hack CE; Clewell HJ
    Risk Anal; 2007 Aug; 27(4):947-59. PubMed ID: 17958503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the dermal absorption of m-xylene vapor in humans using breath sampling and physiologically based pharmacokinetic analysis.
    Loizou GD; Jones K; Akrill P; Dyne D; Cocker J
    Toxicol Sci; 1999 Apr; 48(2):170-9. PubMed ID: 10353308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human inhalation exposures to toluene, ethylbenzene, and m-xylene and physiologically based pharmacokinetic modeling of exposure biomarkers in exhaled air, blood, and urine.
    Marchand A; Aranda-Rodriguez R; Tardif R; Nong A; Haddad S
    Toxicol Sci; 2015 Apr; 144(2):414-24. PubMed ID: 25601989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
    Chou WC; Lin Z
    Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations.
    Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L
    PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification.
    Krauss M; Burghaus R; Lippert J; Niemi M; Neuvonen P; Schuppert A; Willmann S; Kuepfer L; Görlitz L
    In Silico Pharmacol; 2013; 1():6. PubMed ID: 25505651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Bayesian population physiologically based pharmacokinetic (PBPK) modeling and Markov chain Monte Carlo simulations to pesticide kinetics studies in protected marine mammals: DDT, DDE, and DDD in harbor porpoises.
    Weijs L; Yang RS; Das K; Covaci A; Blust R
    Environ Sci Technol; 2013 May; 47(9):4365-74. PubMed ID: 23560461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the reliability of PBPK models using data from methyl chloride-exposed, non-conjugating human subjects.
    Jonsson F; Bois FY; Johanson G
    Arch Toxicol; 2001 Jun; 75(4):189-99. PubMed ID: 11482516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifetime PCB 153 bioaccumulation and pharmacokinetics in pilot whales: Bayesian population PBPK modeling and Markov chain Monte Carlo simulations.
    Weijs L; Roach AC; Yang RS; McDougall R; Lyons M; Housand C; Tibax D; Manning T; Chapman J; Edge K; Covaci A; Blust R
    Chemosphere; 2014 Jan; 94():91-6. PubMed ID: 24080004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans.
    Tardif R; Charest-Tardif G; Brodeur J; Krishnan K
    Toxicol Appl Pharmacol; 1997 May; 144(1):120-34. PubMed ID: 9169076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air. I. Toluene and m-xylene.
    Laparé S; Tardif R; Brodeur J
    Int Arch Occup Environ Health; 1993; 64(8):569-80. PubMed ID: 8314616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexposure of man to m-xylene and methyl ethyl ketone. Kinetics and metabolism.
    Liira J; Riihimäki V; Engström K; Pfäffli P
    Scand J Work Environ Health; 1988 Oct; 14(5):322-7. PubMed ID: 3201193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats.
    Sweeney LM; MacCalman L; Haber LT; Kuempel ED; Tran CL
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):151-63. PubMed ID: 26145831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying a Global Sensitivity Analysis Workflow to Improve the Computational Efficiencies in Physiologically-Based Pharmacokinetic Modeling.
    Hsieh NH; Reisfeld B; Bois FY; Chiu WA
    Front Pharmacol; 2018; 9():588. PubMed ID: 29937730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.
    Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Computational Workflow for Probabilistic Quantitative
    McNally K; Hogg A; Loizou G
    Front Pharmacol; 2018; 9():508. PubMed ID: 29867507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.